Hepatotoxicity and -carcinogenicity of the fumonisins in rats: A review regarding mechanistic implications for establishing risk in humans

Advances in Experimental Medicine and Biology

Volumn 392, Issue , 1996, Pages 279-296

  Gelderblom, W C A ^a   Snyman, S D ^a   Abel, S ^a   Lebepe Mazur, S ^a   Smuts, C M ^a,b   Van Der Westhuizen, L ^a   Marasas, W F O ^a   Victor, T C ^c   Knasmuller S ^d   Huber, W ^d  

^a Programme on Mycotoxins and Experimental Carcinogenesis   (South Africa)

^b Nutritional Intervention Res Unit   (South Africa)

^c SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^d UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; FUMONISIN B1;

CANCER RISK; CARCINOGENESIS; CARCINOGENICITY; CELL PROLIFERATION; CONFERENCE PAPER; CYTOTOXICITY; LIPOGENESIS; LIVER TOXICITY; OXIDATIVE STRESS; PRIORITY JOURNAL; RISK ASSESSMENT; TUMOR PROMOTION;

EID: 9044224763     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4899-1379-1_24     Document Type: Conference Paper

References (62)

1. Ames, B.N.; Gold, L.S. Dietary carcinogens, environmental pollution, and cancer: some misconceptions. Med. Oncol. & Tumor Pharmacother. 1990, 7, 69-85.
2. Barstch, H.; Ohshima, H.; Pignatelli, B.; Calmels, S. Endogenously formed N-nitroso compounds and nitrosating agents in human etiology. Pharmacogenetics 1992, 2, 272-277.
3. Begin, M.E.; Ells, G.; Horribin, D.F. Polyunsaturated fatty acid-induced cytotoxicity against tumor cells and its relationship to lipid peroxidation. J. Natl. Cancer Inst. 1992, 80, 188-194.
4. Bishop, J.M. The molecular genetics of cancer. Science 1987, 235, 305-311.
5. Bressac, B.; Kew, M.; Wands, J.; Ozturk, M. Selective G to T mutations of the p53 gene in hepatocellular carcinoma from South Africa. Nature 1991, 350, 429-432.
6. Butterworth, B.E.; Goldsworthy, T.L. The role of cell proliferation in multistage carcinogenesis. Proc. Soc. Exp. Biol. Med. 1991, 683-687.
7. 1 in maize naturally contaminated with aflatoxins. Fd. Chem. Toxic. 1993, 31, 995-998.
8. 14C-labelled fumonisin B mycotoxins with primary hepatocytes cultures. Fd Chem. Toxicol. 1994, 32, 627-632.
9. Cohen, S.M.; Ellwein, L.B. Cell proliferation in carcinogenesis. Science 1990, 249, 1007-1011.
10. Cohen, S.M.; Ellwein, L.B. Carcinogenesis mechanisms: The debate continues. Science 1991, 252, 902-904.
11. Columbano, A.; Ledda-Columbano, G.M. Coni, P.; Pichiri-coni, G.; Curto, M.; Pani, P. Chemically induced cell proliferation and carcinogenesis: differential effect of compensatory cell proliferation and mitogen-induced direct hyperplasia on hepatocarcinogenesis in the rat. Progress. Clin. Biol. Res. 1991, 369, 217-225.
12. 1 and other mycotoxins in moldy maize collected from People's Republic of China in regions with high incidences of esophageal cancer. Appl. Environ. Microbiol. 1994, 60, 847-852.
13. Farber, E. Clonal adaptation during carcinogenesis. Biochem. Pharmacol. 1983, 39, 1837-1846.
14. Farber, E.; Chen, Z-Y.; Harris, L.; Lee, G.; Rinaudo, J.S.; Perera, F.P. Molecular cancer epidemiology: A new tool on cancer prevention. J. Natl. Cancer Inst. 1987, 78, 887-897.
15. Farber, E.; Chen, Z-Y.; Harris, L.; Lee, G.; Rinaudo, J.S.; Roomi, W.M.; Rotstein, J.; Semple, E. The biochemical-molecular pathology of the stepwise development of liver cancer: new insights and problems. In Liver Cell Carcinoma; Bannasch, P., Keppler, D., Weber, G., Eds.; Kluwer Academic Publishers: Dordreccht,Boston,London, 1989; pp 273-291.
16. Farber, E. Hepatocytc proliferation in stepwise development of experimental liver cell cancer. Digest. Disease and Science 1991, 36, 973-978.
17. Farber, E.; Rubin H. Cellular adaptation in the origin and development of cancer. Cancer Res. 1991, 51, 2751-2761.
18. Farber, E. Is carcinogenesis fundamentally adversarial confrontational or physiologic-adaptive? J. Invest.Dermatol. 1993, 100, 251s-253s.
19. Gavino, V.C.; Miller, J.S.; Ikharebha, S.O.; Milo, G.E.; Maizewell, D.G. Effect of polyunsaturated fatty acids and antioxidants on lipid peroxidation in tissue cultures. J. Lipid Res. 1981, 22, 763-769.
20. Gelderblom, W.C.A.; Jaskiewics, K.; Marasas, W.F.O.; Thiel, P.G.; Horak, R.M.; Vleggaar, R.; Kriek, N.P.J. Fumonisins - novel cancer promoting activity produced by Fusarium moniliforme. Appl. Environ. Microbiol. 1988, 54, 1806-1811.
21. Gelderblom, W.C.A.; Snyman, S.D. Mutagenieity of potentially carcinogenic mycotoxins produced by Fusarium moniliforme. Mycotoxin Res. 1991, 7, 46-52.
22. 1, in rats. Carcinogenesis 1991, 12, 1247-1251.
23. Gelderblom, W.C.A.; Semple, E.; Farber, E. The cancer initiating potential of the fumonisin mycotoxins produced by Fusarium moniliforme. Carcinogenesis 1992, 13, 433-437.
24. Gelderblom, W.C.A.; Cawood, M.E.; Snyman, S.D.; Vleggaar, R.; Marasas, W.F.O. Structure-activity relationships of fumonisins in short-term carcinogenesis and cytotoxicity assays. Fd. Chem. Toxicol. 1993, 31, 407-414.
25. 1 dosimetry in relation to cancer initiation in rat liver. Carcinogenesis 1994, 15, 209-214.
26. 1 on rat hepatocytes in primary culture. Carcinogenesis 1995, 16, 625-631.
27. 1 on protein and lipid synthesis in primary hepatocytes. Food Chem Toxicol. 1996, In press.
28. Ghoshal, A.K.; Rushmore, T.H.; Farber, E. Initiation of carcinogenesis by a dietary deficiency of choline in the absence of added carcinogens. Cancer Lett. 1987, 36, 289-296.
29. Grasl-Kraupp, B.; Waldhor, T.; Huber, W.; Schulte-Herman, R. Glutathione S-transferase isoenzymes patterns in different subtypes of enzyme-altered rat liver foci treated with the peroxisome proliferator nafenopin or with phenobarbital. Carcinogenesis 1993, 14, 2407-2412.
30. Halliwell, B. Free radicals, antioxidants, and human disease: curiosity, cause, or consequence. The Lancet 1994, 344, 721-724.
31. Handler, J.A.; Danilowics, M.; Eling, T.E. Mitogenic signalling by epidermal growth factor requires arachidonic acid metabolism in BALB/c 3T3 cells. J. Biol. Chem. 1990, 265, 3669-3673.
32. Hoel, D.G.; Haseman, J.K.; Hogan, M.D.; Huff, J.; McConnell, E. The impact of toxicity on carcinogenicity studies: implications for risk assessment. Carcinogenesis 1988, 9, 2045-2052.
33. Huber, W.W.; Kraupp-Grasl, B.; Gschwentner, C. Influence of cicadian rhythm, feeding rhythm and fat charge on lipid peroxidation under peroxisome proliferation by nafenopin. Naunyn-Schmiedeberg's Arch. Pharmacol. 1992, 345 Suppl. 153
34. Kato, T.; Imaida, K.; Ogawa, K.; Hesegawa, R.; Shirai, T.; Tatematsu, M. Three-dimensional analysis of glutathione S-transferase placental form-positive lesion development in early stages of rat hepatocarcinogenesis. Jpn. J .Cancer Res. 1993, 84, 1252-1257.
35. Kraupp-Grasl, B.; Huber, W.; Taper, H.; Schulte-Hermann, R. Increased susceptibility of aged rats to hepatocarcinogenesis by the peroxisome proliferator nafenopin and the possible involvement of altered liver foci occurring spontaneously. Cancer Res. 1991, 51, 666-671.
36. Kuiper-Goodman, T. Uncertainties in the risk assessment of three mycotoxins: aflatoxin, ochratoxin, and zearalenone. Can.J. Physiol. Pharmacol. 1990, 68, 1017-1024.
37. Manjeshwar, S.; Rao, P.M.; Rajalakshmi, S.; Sarma, D.S.R. Inhibition of DNA synthesis by phenobarbital in primary cultures of hepatocytes from normal liver and from hepatic nodules. Carcinogenesis 1992, 13, 2287-2291.
38. Maizewell, D.G.; Morisaki, N. Fatty acid paradoxes in the control of cell proliferation: prostaglandins, lipid peroxides, and co-oxidation reactions. In Free Radicals in Biology VI; Pryor, W.A., Ed.; Academic Press INC: Orlando, Florida, USA, London, 1984; pp 95-148.
39. Melnick, R.L.; Huff, J. Liver carcinogenesis is not a predictive outcome of chemically induced hepatocyte proliferation. Toxicol. Indust. Health 1993, 9, 415-438.
40. Morisaki, N.; Lindsey, J.A.; Milo, G.E.; Maizewell, D.G. Fatty acid metabolism and cell proliferation. Effect of prostaglandin biosynthesis either from exogenous fatty acid metabolism or endogenous fatty acid release with hydralazine. Lipids 1983, 18, 349-352.
41. Nagai, M.K.; Armstrong, D.; Farber, E. Induction of resistant hepatocytes by clofibrate, a non-genotoxic carcinogen. Proc. Am. Ass. Cancer Res. 1993, 34, 164.
42. Nolan, R.D.; Danliowicz, R.M.; Eling, T.E. Role of arachidonic acid metabolism in the mitogenic response of Balb/c 3T3 fibroblasts to epidermal growth factor. Molecular Pharmacol. 1988, 33, 650-656.
43. Norred W.P.; Plattner, R.D.; Vesonder, R.F.; Bacon, C.W.; Voss, K.A. Effects of selected secondary metabolites of Fusarium moniliforme on unscheduled synthesis of DNA by primary rat hepatocytes. Fd. Chem. Toxicol. 1992, 30, 233-237.
44. Pichiri-coni, G.; Coni, P.; Laconi, E.; Schwarze, P.E.; Seglen, P.O.; Rao, P.M.; Rajalakshimi, S.; Sarma, D.S.R. Studies on the mitoinhibitory effect of orotic acid on hepatocytes in primary culture. Carcinogenesis 1990, 11, 981-984.
45. Rao, M.S.; Reddy, J.K. An overview of peroxisome proliferator-induced hepatocarcinogenesis. Environ. Health Perspect. 1991, 93, 205-209.
46. Reifferscheid, G.; Heil, J.; Oda, Y.; Zahn, R.K. A microplate version of SOS/umu-test for rapid detection of genotoxins and genotoxic potential of environmental samples. Mutat Res. 1991, 253, 215-222.
47. Rheeder, J.P.; Marasas, W.F.O.; Thiel, P.G.; Sydenham, E.W.; Shephard, G.S.; Van Schalkwyk, D.J. Fusarium moniliforme and fumonisins in maize in relation to human esophageal cancer in Transkei. Phytopathology 1992, 82, 353-357.
48. Rheeder, J.P.; Sydenham, E.W.; Marasas, W.F.O.; Thiel, P.G.; Shephard, G.S.; Schlecther, M.; Stockenström, S.; Cronje, D.E.; Viljoen, T.H. Ear-rot fungi and mycotoxins in South Africa maize of the 1989 crop exported to Taiwan. Mycopathologia 1994, 127, 35-41.
49. Roomi, W.M.; Rotstein, J.; Semple, E. The biochemical-molecular pathology of the stepwise development of liver cancer: new insights and problems. In The molecular biology of carcinogenesis; Bannasch, P., Keppler, D., Pilot, H.C. Cancer 1993, Suppl. 72, 962-970.
50. Ross, R.K.,; Yaun, J.M.,; Yu, M.C.,; Wogan, G.N., Qian, G.S. Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. Lancet 1992, 339, 9343-9346.
51. Satoh, K.; Hatayama, I.; Tateoka, N.; Tamai, K.; Shimizu, T.; Tatematsu, M.; Ito, N.; Sato, K. Transient induction of single GST-P positive hepatocytes by DEN. Carcinogenesis 1989, 10, 2107-2111.
52. Sheffield, V.C.; Beck, J.S.; Kwitek, A.E.; Sandstrom, D.W.; Stone, E.M. The sensitivity of single-strand conformation polymorphism analyses for the detection of single base substitutions. Genomics 1993, 16, 325-332.
53. 1, in rats. Toxicon 1992, 30, 768-770.
54. Smith, J.E.; Lewis, C.W.; Anderson, J.G.; Solomons, G.L. Eds.; Mycotoxins in human nutrition and health. Directorate-General XII, Science, Research and Development, EUR 16048 EN, 1994, pp 43-48.
55. Sydenham, E.W.; Shephard, G.S.; Thiel, P.G.; Marasas, W.F.O.; Stokenström, S. Fumonisin contamination of commercial maize-based human foodstuffs. J. Agric. Food Chem. 1991, 39, 2014-2018.
56. Thiel, P.G.; Marasas, W.F.O.; Sydenham, E.W.; Shephard, G.S.; Gelderblom, W.C.A. The implications of naturally occurring levels of fumonisins in maize for human and animal health. Mycopathologia 1992, 177, 3-9.
57. Viljoen, J.H.; Marasas, W.F.O.; Thiel P.G. Fungal infection and mycotoxin contamination of commercial maize. In Cereal Science and Technology: Impact on a Changing South Africa; Taylor, J.R.N., Randall, P.G., Viljoen, J.H., Eds.; CSIR, Pretoria, 1993.
58. 1. Natural Toxins 1993, 1, 222-228.
59. Ward, J.M.; Henneman, J.R. Naturally-occurring age-dependent glutathione S-transferase P immunoreactive hepatocytes in aging female F344 rat liver as potential promotable targets for non-genotoxic carcinogens. Cancer Lett. 1990, 52, 187-195.
60. Ward, J.F.; Limoli, C.L.; Calabro-Jones, P.; Evans, J.W. Radiation vs. chemical damage to DNA. In Anticarcinogenesis and Radiation Protection; Cerutti P.A., Nygaard, O.F., Simic, M.G., Eds.; Plenum Press: New York, 1987.
61. Weinstein, I.B. Nonmutagenic mechanism in carcinogenesis: role of protein kinase C in signal transduction and growth control. Environ. Health Perspec. 1991, 93, 175-179.
62. 1 cells. Toxicol. Appl. Pharmacol. 1992, 114, 9-15.